ConductScience.org, home

Paper41783166

Histone deacetylases: Function in tumor development and therapeutic prospects (Review).

Lin R and 3 others. Oncol Lett, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Histone deacetylases: Function in tumor development and therapeutic prospects (Review). Papers, record 41783166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41783166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histone deacetylases: Function in tumor development and therapeutic prospects (Review).
PubMed
Journal
Oncol Lett
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin RRunling
2Zhang YYu
3Li HHong
4Liang FFan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References175

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140380049Epigenetic reprogramming and antitumor immune responses in gliomas: a systematic review.Med Oncol2025https://conductscience.org/library/papers/40380049PubMed
236230631Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone.Cancers (Basel)2022https://conductscience.org/library/papers/36230631PubMed
332599665Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma.Int J Cancer2020https://conductscience.org/library/papers/32599665PubMed
441563767MIG-6 Regulates HDAC1-Mediated Angiogenesis and Tumorigenesis in PTEN-Deficient Endometrioid Endometrial Cancer.Mol Cancer Res2026https://conductscience.org/library/papers/41563767PubMed
539676171HDACi combination therapy with IDO1i remodels the tumor microenvironment and boosts antitumor efficacy in colorectal cancer with microsatellite stability.J Nanobiotechnology2024https://conductscience.org/library/papers/39676171PubMed
632315388FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.Blood2020https://conductscience.org/library/papers/32315388PubMed
736102738HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer.Cancer Res2022https://conductscience.org/library/papers/36102738PubMed
835152694Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity.J Med Chem2022https://conductscience.org/library/papers/35152694PubMed
937659201HDAC11: A novel target for improved cancer therapy.Biomed Pharmacother2023https://conductscience.org/library/papers/37659201PubMed
1034903992Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma.Iran J Pharm Res2021https://conductscience.org/library/papers/34903992PubMed
1133189849Anticancer properties of chimeric HDAC and kinase inhibitors.Semin Cancer Biol2022https://conductscience.org/library/papers/33189849PubMed
1232903337Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells.Front Cell Dev Biol2020https://conductscience.org/library/papers/32903337PubMed
1340164393Synthesis and biological evaluation of novel 4-Arylaminoquinolines derivatives as EGFR/HDAC inhibitors.Bioorg Med Chem Lett2025https://conductscience.org/library/papers/40164393PubMed
1433756235Discovery of novel tetrahydrobenzo[b]thiophene-3-carbonitriles as histone deacetylase inhibitors.Bioorg Chem2021https://conductscience.org/library/papers/33756235PubMed
1536771118Entinostat-Bortezomib Hybrids against Multiple Myeloma.Molecules2023https://conductscience.org/library/papers/36771118PubMed
1625129440Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest.Tumour Biol2014https://conductscience.org/library/papers/25129440PubMed
1736831683DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.Cancers (Basel)2023https://conductscience.org/library/papers/36831683PubMed
1835277183HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35277183PubMed
1936849955Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia.Exp Hematol Oncol2023https://conductscience.org/library/papers/36849955PubMed
2032350373Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab.Leukemia2021https://conductscience.org/library/papers/32350373PubMed

See all 175 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42883867Targeting Aromatase and HDACs in Hormone Receptor-Positive Breast Cancer: Molecular Interplay, Endocrine Resistance and Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/42883867PubMed
42742903Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer.Genes Genomics2026https://conductscience.org/library/papers/42742903PubMed
42649936Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42649936PubMed
42539113Dual Epigenetic and Chaperone Inhibition Disrupts Hypoxia Signaling and Tumor Progression in 3-D Models of Triple-Negative Breast Cancer.Res Sq2026https://conductscience.org/library/papers/42539113PubMed
42198363Hypophosphatemia as a Potential Class Effect of Histone Deacetylase Inhibitors: Evidence from Disproportionality Analysis and Mendelian Randomization Analysis of Drug Targets.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198363PubMed

Download CSV of cited by

Genes44

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CRBN51185PubTator's text mininghttps://conductscience.org/library/genes/51185NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
FGF188817PubTator's text mininghttps://conductscience.org/library/genes/8817NCBI Gene
FOXO12308PubTator's text mininghttps://conductscience.org/library/genes/2308NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
HDAC13065PubTator's text mininghttps://conductscience.org/library/genes/3065NCBI Gene
HDAC1083933PubTator's text mininghttps://conductscience.org/library/genes/83933NCBI Gene
HDAC1179885PubTator's text mininghttps://conductscience.org/library/genes/79885NCBI Gene
HDAC23066PubTator's text mininghttps://conductscience.org/library/genes/3066NCBI Gene
HDAC38841PubTator's text mininghttps://conductscience.org/library/genes/8841NCBI Gene

See all 44 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41783166

GET https://conductscience.org/api/papers/v1/41783166/references?page=2